Michael W. Bonney
Chairman
Immunic, Inc. (IMUX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael W. Bonney
Michael W. Bonney is recorded as Chairman at Immunic, Inc. (IMUX). Immunic, Inc. reported in an 8-K filed August 11, 2026 that Michael W. Bonney was appointed Chair of the Board of Directors, effective May 16, 2026. Immunic, Inc. reported in an 8-K filed May 19, 2026 that Michael W. Bonney was appointed Chair of the Board, effective May 16, 2026.
“Michael W. Bonney has been appointed as Chair of the Board of Directors, effective May 16, 2026.”
“On May 16, 2026 (the "Effective Date"), the board of directors (the "Board") of Immunic, Inc., a Delaware corporation (the "Company") appointed Michael W. Bonney as Chair of the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-05-16–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Immunic, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Daniel Vitt CEO
- Duane D. Nash CEO
- Duane Nash CEO
- Erik Lundgren CEO, Board Member
- Russell J. Cox CEO
- Simona Skerjanec Chairman, Board Member
- Glenn Whaley CFO
- Jason Tardio COO
- Inderpal Singh General Counsel
- Barclay Phillips Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.